Stock Track | Inspire Medical Systems Plunges 12.30% in Pre-market on Disappointing Guidance and Analyst Price Target Cuts

Stock Track02-12 17:44

Inspire Medical Systems' stock experienced a significant pre-market plunge of 12.30%, indicating heavy selling pressure ahead of the trading session.

The sharp decline follows the company's release of its 2026 financial outlook, which fell short of analyst expectations. Inspire Medical Systems projected revenue between $950 million and $1 billion for the year, below the FactSet consensus estimate of $1.01 billion.

In response to the disappointing guidance, multiple Wall Street firms, including RBC, Jefferies, JP Morgan, and Leerink Partners, significantly reduced their price targets for the stock. The collective analyst downgrades amplified negative sentiment among investors, contributing to the pre-market selloff.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment